Page 300 - SRL Diagnostics

M TO R

5200R - REDUCING SUBSTANCES IN PAEDIATRIC URINE SPECIMENS
BY QUALITATIVE CHEMICAL ANALYSIS
SPECIMEN: 12 -14 HRS FASTING SERUM (LIPEMIC SAM-  R
PLE SHOULD BE AVOIDED) + CLINICAL HISTORY + (AGE
& GENDER IS MANDATORY), 10 ML
À REPORTED ON: SAME DAY OF
ACCEPTANCE CUT OFF: DAILY: 16:30 HRS RUN
RUN DAY: DAILY: 16:30 HRS

5170 - RETICULOCYTE COUNT, BLOOD
BY MANUAL
SPECIMEN: K2EDTA WB, 3 ML  A
ACCEPTANCE CUT OFF: DAILY: 16:30 HRS
À REPORTED ON: SAME DAY OF
RUN DAY: DAILY: 16:30 HRS RUN

4520 - RETINOL BINDING PROTEIN (RBP)
BY NEPHELOMETRY
SPECIMEN: 10 -12 HRS FASTING SERUM + CLINICAL  2-8°C (7 DAYS); F (>7 -90 DAYS, IF
HISTORY + (AGE & GENDER IS MANDATORY), 2 ML (1 F WITHIN 24 HRS. OF COLLEC-
ML) TION)
ACCEPTANCE CUT OFF: 2ND & 4TH SUN: 15:00 HRS REPORTED ON: 3RD DAY OF
À
RUN DAY: 2ND & 4TH MON: 12:00 HRS RUN

RD1410 - RETT SYNDROME DNA SEQUENCING ( MECP2 MUTATION)
BY PCR SEQUENCING
SPECIMEN: EDTA WHOLE BLOOD + CLINICAL HISTORY,  A
5 ML (3 ML)
ACCEPTANCE CUT OFF: SUN: 15:00 HRS À REPORTED ON: 10TH DAY OF
RUN
RUN DAY: TUES: 09:30 HRS

5008 - RHEUMATOID ARTHARITIS PANEL ( ANA, RHEUMATOID FACTOR, ANTI CCP)
BY IMMUNOTURBIDIMETRY/ ECLIA/ IMMUNOFLORESCENCE
SPECIMEN: 12 -14 HRS FASTING SERUM (LIPEMIC SAM-  2-8°C (7 DAYS); F (>7 -90 DAYS, IF
PLE SHOULD BE AVOIDED) + CLINICAL HISTORY + F WITHIN 24 HRS. OF COLLEC-
(AGE & GENDER IS MANDATORY), 2 ML (1.5 ML) TION)
ACCEPTANCE CUT OFF: DAILY: 16:30 HRS
À REPORTED ON: 3RD DAY OF
RUN DAY: DAILY: 16:30 HRS RUN
288